Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | DCTH | SIBN |
|---|---|---|
| Price | $15.38 | $19.10 |
| Change today | ▼ 0.19% | ▼ 2.30% |
| Market cap | $533.67M | $856.03M |
| Return, 3 months | +13.8% | +9.6% |
| Return, year to date | +52.3% | -3.1% |
| Return, 1 year | +38.6% | +25.6% |
| P/E (TTM) | 1,538.0 | -57.9 |
| P/B | 4.4 | 4.7 |
| P/E percentile vs own 5y | 97th | 1st |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +20.6% | +15.2% |
| Net profit growth (YoY) | -1.1% | +33.6% |
| Gross margin | 87.1% | 79.5% |
| Operating margin | -1.9% | -8.3% |
| Net margin | 0.6% | -6.9% |
| Return on equity | 0.5% | -8.3% |
| Analyst target vs. price | +52.8% | +28.3% |
| Analyst buy share | 100% | 100% |
| RSI (14) | 44 | 54 |
| 30-day volatility | 29.8% | 35.1% |
| Max drawdown, 1 year | -33.7% | -45.7% |
| Trend read | Leaning bearish | Strong uptrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
